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Abstract  25 
Analysing the evolution of FIV on the intra-host level is important, in order to address 26 
whether the diversity and composition of viral quasispecies affects disease 27 
progression. 28 
We examined the intra-host diversity and the evolutionary rates of the entire env and 29 
structural fragments of the env sequences obtained from sequential blood samples in 30 
43 naturally infected domestic cats that displayed different clinical outcomes. We 31 
observed in the majority of cats that FIV env showed very low levels of intra-host 32 
diversity. We estimated that env evolved at the rate of 1.16 x 10
-3
 substitutions per site 33 
per year and demonstrated that recombinant sequences evolved faster than non-34 
recombinant sequences. It was evident that the V3-V5 fragment of FIV env displayed 35 
higher evolutionary rates in healthy cats than in those with terminal illness. Our study 36 
provided the first evidence that the leader sequence of env, rather than the V3-V5 37 
sequence, had the highest intra-host diversity and the highest evolutionary rate of all 38 
env fragments, consistent with this region being under a strong selective pressure for 39 
genetic variation.  40 
Overall, FIV env displayed relatively low intra-host diversity and evolved slowly in 41 
naturally infected cats. The maximal evolutionary rate was observed in the leader 42 
sequence of env. Although genetic stability is not necessarily a prerequisite for 43 
clinical stability, the higher genetic stability of FIV compared to HIV might explain 44 
why many naturally infected cats do not progress to AIDS rapidly.   45 
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Introduction 46 
Deciphering the evolution of feline immunodeficiency virus (FIV) is essential for 47 
understanding why some infected cats have normal lifespans while others progress 48 
rapidly to AIDS. The generation of polymorphic populations (Eigen, 1993) and the 49 
potentially high intra-host diversity of RNA viruses are features attributable to their 50 
biology as well as the unique characteristics of retroviral reverse transcription 51 
(Domingo, 2000). Improved understanding of the dynamics of viral populations on 52 
the intra-host level will lead to the development of more effective diagnostic tests, 53 
control strategies and, ultimately, will inform the design of the next generation of FIV 54 
vaccines, since the limited efficacy of the current commercial vaccine (Dunham et al., 55 
2006) is likely attributable to the high genetic diversity of naturally occurring viruses. 56 
The majority of FIV phylogenetic analyses have focused on sequence variation at the 57 
population level (Carpenter et al., 1998; Olmsted et al., 1992; Pistello et al., 1997; 58 
Samman et al., 2011; Teixeira et al., 2010) and highlighted the high variability of the 59 
V3-V5 region of the env gene, which has been used to classify FIV into 6 distinct 60 
subtypes (A, B, C, D, E and putative subtype F) (Marcola et al., 2013; Sodora et al., 61 
1994). Employing GARD (Kosakovsky Pond et al., 2006a) and jpHMM (Schultz et 62 
al., 2006) recombination detection methods, we recently observed an abundance of 63 
recombinant envs in natural FIV infection, emphasizing the important role of 64 
recombination in generating viral diversity at the population level and highlighting the 65 
limitations of the current phylogenetic classification of FIV (Bęczkowski et al., 66 
2014a). 67 
Mutations also contribute to viral diversity, although little is known about the 68 
evolutionary rate and the within-host viral diversity of the entire FIV env in natural 69 
infection (Table 1). In HIV-1 infected individuals, quasispecies composition varies 70 
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greatly, with some studies reporting 10% diversity in long-term infected individuals 71 
(Delwart et al., 1997).  It has also been proposed that intra-host diversity could 72 
influence the outcome of disease, and that the rate of viral evolution decreases during 73 
disease progression (Delwart et al., 1997; Shankarappa et al., 1999). 74 
Selection measures have been applied previously to assess forces acting on the 75 
evolution of different retroviral genes and at different regions within the same gene 76 
(Choisy et al., 2004). For example, in HIV-1 infection, gag is under negative selection 77 
pressure (Kils-Hutten et al., 2001), while env evolution is generally shaped by 78 
positive selection pressure (Wolfs et al., 1990). Since gag encodes structural proteins, 79 
its conserved nature is essential to maintain viral integrity. In contrast, HIV-1 env 80 
encodes a heavily glycosylated envelope glycoprotein in which mutations in N-linked 81 
glycosylation sites are important for immune evasion (Yamaguchi & Gojobori, 1997). 82 
By analogy with HIV, we predict that FIV env is under a similar positive selection 83 
pressure as its human counterpart, but relatively little is known about the 84 
glycosylation pattern or selection forces acting on FIV Env in naturally infected cats. 85 
To our knowledge, there are no data available concerning rates of evolution of the 86 
entire ORF of FIV env which, in contrast to primate retroviruses, contains an 87 
unusually long leader/signal region (Verschoor et al., 1993). Evolutionary studies of 88 
HIV-1 infection (Korber et al., 2000; Leitner & Albert, 1999; Lukashov et al., 1995; 89 
Shankarappa et al., 1999; Zhang et al., 1997) suggest that within-host evolution is 90 
influenced by both viral- and host-dependent factors. Whereas some studies reported 91 
increased evolutionary rates during the early stages of infection, declining towards 92 
terminal stage disease (Delwart et al., 1997; Shankarappa et al., 1999), others did not 93 
observe a similar pattern (Mikhail et al., 2005). Nevertheless, the assumption that the 94 
virus is under constant pressure in immunocompetent individuals and evolves at a 95 
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high rate in response to a changing environment, provides a plausible explanation for 96 
differences in evolutionary rates at different stages of disease (Lukashov et al., 1995). 97 
It is apparent that rates of evolution are dependent on the combined effects of host and 98 
viral factors, demonstrated by comparisons of the evolutionary tempo of different 99 
HIV-1 subtypes (Abecasis et al., 2009) and differences in replication rates of HIV-1 100 
and HIV-2 (MacNeil et al., 2007b). 101 
Our ability to understand immune evasion, and to predict the outcome of FIV 102 
infection, depends on understanding how the intra-host evolution of FIV differs 103 
within and among cats. For this reason, we examined env sequences collected serially 104 
over 12 months from 2 distinct cohorts of naturally infected cats that developed 105 
different clinical outcomes. Our specific aims were to: 1) quantify viral diversity, 106 
selection, and rates of evolution in naturally infected cats and 2) determine whether 107 
the evolutionary rate correlated with the clinical outcomes of FIV infection.  108 
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Results  109 
Phylogenetic inference 110 
The Maximum Likelihood (ML) tree constructed using the entire data set (Additional 111 
file 1) revealed high genetic diversity in FIV env at the population level (overall mean 112 
pairwise distance of 14.1%). Although more than 41% of cats were infected with 113 
circulating recombinant viruses, we found no evidence of within host recombination 114 
(Bęczkowski et al., 2014a). On the intra-host level, sequential sequences amplified 115 
from 93% (40/43) of cats clustered together in monophyletic groups, while sequences 116 
from 3 cats (M5, P8 and P21), amplified at different time points, showed incongruent 117 
phylogenetic assignment (Fig. 1). Sequences from a parent-offspring pair (cat M1 was 118 
an offspring of female M11) were classified as non-recombinant clade B and clustered 119 
closely together, with an overall mean pairwise distance of 0.3% (Additional file 2-120 
Fig. S1).   121 
Intra-host diversity 122 
Having excluded sequences from the 3 cats that formed non-monophyletic groups, the 123 
mean pairwise distances for env within cats ranged from 0% to 2.9% (median 0.13), 124 
0% to 1.9% (median 0.11) and 0% to 1.9% (median 0.17), for early (A), intermediate 125 
(B) and late (C) time points, respectively (Additional file 3-Table S1). When we 126 
compared the diversity of structural fragments of the env, although not statistically 127 
significant (p=0.29), the leader region displayed the highest variation at the intra-host 128 
level; the median overall mean pairwise distances for each time point were 0.2%, 129 
0.2% and 0.27%, respectively (Fig. 2; Additional file 3-Table S1). 130 
Selection 131 
The mean ω value (dN/dS ratio) determined by SLAC for the env sequences from 132 
both cohorts was 0.34. Examining the entire data set, the SLAC analysis indicated 14 133 
(1.6%) positively and 201 (23%) negatively selected sites. FEL reported 22 (2.5%) 134 
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positively and 391 (44.8%) negatively selected sites, while IFEL indicated 24 (2.7%) 135 
and 377 (43.2%) sites under positive and negative selection respectively. Positively 136 
selected sites, consistently identified by the three methods (Additional file 4-Table 137 
S2), were restricted to specific regions of env, with a high proportion (5/10, 50%; sites 138 
8, 62, 96, 156, 157) lying within the leader region (Fig. 3). The selection hot spots at 139 
positions 400 and 750 were located within B cell epitopes identified in previous 140 
studies (Lombardi et al., 1993; Pancino et al., 1993) (Fig. 3). An investigation of the 141 
global distribution of potential N-linked glycosylation sites (PNGS) for the presence 142 
of fixed and shifting sequons revealed that, regardless of the high genetic variability 143 
of the analysed sequences (n=329), conserved PNGS did exist (Fig. 3). However, 144 
none of the predicted PNGS fell within sites identified as being under positive 145 
selection. 146 
Rates of molecular evolution 147 
For all cats in the study, env was estimated to evolve at a mean rate of 1.16 x 10
-3
 with 148 
0.7-1.67 95% HPD substitutions per site per year under a relaxed log normal clock 149 
model (Additional file 5 - Table S3) with the first and second codon positions 150 
evolving at a lower rate than the third codon position (0.95 with 0.90-0.98 95% HPD 151 
versus 1.1 with 1.02-1.19 95% HPD). To determine whether specific regions of the 152 
env gene evolved at different rates, we estimated the clock rate for the leader, the V3-153 
V5 and the non-variable (NV) regions. The leader region evolved at the highest rate 154 
(3.43 x 10
-3
 with 1.55-5.6 95% HPD substitutions per site per year under a relaxed log 155 
normal clock model) in comparison to other fragments, while the evolutionary rate of 156 
the V3-V5 region, commonly regarded as highly variable, was over 3 times lower 157 
(1.08 x 10
-3
 with 0.5-1.74, 95% HPD substitutions per site per year under a relaxed 158 
log normal clock model) (Fig. 4; Additional file 5 -Table S3). 159 
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Since the individually housed cats from the Chicago cohort were generally healthy, 160 
while the majority of group housed cats from the Memphis cohort had high morbidity 161 
and 63% mortality over the study period, we compared the evolutionary rates between 162 
and within the cohorts. Median rates of evolution of the entire env and its fragments 163 
were higher for the sequences from cats in the Chicago cohort (Fig. 4). We 164 
hypothesised that env evolution in healthy cats that remained alive throughout the 165 
study period would be faster than in terminally ill cats that died during the study 166 
period.  Fig. 5 illustrates a comparison of the evolutionary rates for sequences from i) 167 
11 deceased cats and ii) 6 cats that remained alive and generally free of clinical signs 168 
during the study. The entire env, leader and NV fragment evolved at higher rates in 169 
terminally ill animals. This relationship, however, was reversed for the V3-V5 region, 170 
which evolved at a higher rate in cats that remained alive during the study period. 171 
Recombinant env sequences (n=123) evolved 3 times faster than sequences without 172 
any detectable prior history of recombination (n=184), (Additional file 5-Table S3).  173 
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Discussion  174 
Analyses of serial env sequences collected over 12 months from naturally infected 175 
cats offered a rare opportunity to examine the intra-host dynamics and evolution of 176 
FIV. Despite considerable variation among individuals, the overall intra-host diversity 177 
of env (up to 3%) was low compared to primate immunodeficiency viruses 178 
(commonly >5%) (Rambaut et al., 2004; Salemi, 2013). Furthermore, the overall 179 
mean distance between sequences obtained from 2 closely related animals (M1 was 180 
the offspring of M11), following at least 1 postulated transmission event, was 181 
remarkably low. These results suggest that the env sequences were stably maintained 182 
and evolved slowly following vertical transmission. This is consistent with an earlier 183 
study examining V3-V5 env sequence diversity of the Aomori-2 strain of FIV 184 
following vertical transmission; 100% homology was observed between viruses 185 
isolated from a queen and her kitten 48 weeks post transmission (Motokawa et al., 186 
2005). 187 
The apparent discrepancy between low within-host viral diversity and relatively high 188 
diversity of FIV at the population level is intriguing, especially in light of differences 189 
in evolutionary rates demonstrated at the within- and epidemiological levels in HIV 190 
infection (Alizon & Fraser, 2013; Lythgoe & Fraser, 2012). Analysis of FIV 191 
evolutionary rates at the epidemiological level are constrained by the low number of 192 
longitudinal full length FIV env sequences that are available and comprehensive data 193 
sets would be needed to quantify these reliably.  194 
Low diversity and rates of evolution in lentiviruses are commonly associated with 195 
lower pathogenicity. Although HIV-1 and HIV-2 achieve similar proviral loads in 196 
infected individuals, HIV-2 replicates to lower titres in the plasma (Popper et al., 197 
2000), displays a lower rate of sequence evolution (MacNeil et al., 2007a) and lower 198 
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pathogenicity, reflected by a slower decline in CD4+ T cell numbers and slower 199 
disease progression (Marlink et al., 1988; Marlink et al., 1994; Popper et al., 1999; 200 
Whittle et al., 1994). Similarly, bovine immunodeficiency virus (BIV), which has low 201 
pathogenicity, is more closely related to FIV than to primate lentiviruses (Olmsted et 202 
al., 1989) and also exhibits very little sequence variation (Carpenter et al., 2000).  203 
The genetic stability of some lentiviruses could be associated with the fidelity of their 204 
reverse transcriptase (Lewis et al., 1999). Mutations in the catalytic YMDD motif of 205 
HIV-1 and the V148S mutation in SIV (Huisman et al., 2008) have been implicated in 206 
increasing RT fidelity (Olmsted et al., 1989; Operario et al., 2005). It is likely that the 207 
RT of FIV has enhanced fidelity compared to the RT of HIV-1 (Huisman et al., 208 
2008). The presence of almost identical sequences in our study might further indicate 209 
that FIV exhibits a low replication rate during persistent infection, or that most 210 
infections occur via cell-to-cell transfer owing to feline tetherin/BST-2 (Dietrich et 211 
al., 2011). It is also possible that viral evolution is constrained due to the high fitness 212 
cost associated with divergence from the parental virus (Domingo & Holland, 1997). 213 
Whatever the specific mechanism, the low sequence variation of FIV in comparison 214 
to HIV-1 could be indicative of co-adaptation between FIV and its host, which are 215 
thought to have co-existed together for longer than HIV-1 and humans (Pecon-216 
Slattery et al., 2008). Furthermore, the analysis of viral sequence divergence and 217 
disease pathogenesis amongst the Felidae suggest different periods of virus-host co-218 
evolution (Troyer et al., 2008). In general, the least pathogenic viruses appear to have 219 
co-evolved with their hosts for longer periods of time, whereas more virulent strains 220 
have more recent origins. This pattern is reflected in the disease inducing potential of 221 
different species-specific FIVs, with FIV-Pco (FIV of the puma) being the least 222 
pathogenic while FIV-Fca (FIV of the domestic cat) is the most pathogenic. Although 223 
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FIV infection in pumas and lions was previously reported to be asymptomatic, recent 224 
evidence suggests that infected lions do indeed exhibit mild clinical sings of 225 
immunodeficiency, subsequently affecting the lifespans of infected animals (Roelke et 226 
al., 2009). Similar observations have been made recently in SIV-infected 227 
chimpanzees, previously regarded as asymptomatic virus carriers (Terio et al., 2011). 228 
It has been suggested that the slow rate of evolution documented in terminal HIV-1 229 
infection might be linked to the weakened host immune system (Delwart et al., 1997; 230 
Shankarappa et al., 1999). Consistent with this theory, we found that the V3-V5 231 
fragment, which contains neutralisation epitopes and is under immune system 232 
surveillance (Lombardi et al., 1993; Pancino et al., 1993), evolved faster in healthy 233 
cats than in terminally ill cats. In addition, the rates of evolution across all data sets 234 
from the individually housed cats from Chicago (which were generally in good 235 
health) were consistently higher than those estimated for sequences from the cats from 236 
Memphis (which displayed more clinical signs of illness).  237 
Recombination is a potential driver of rapid evolutionary change and plays a 238 
significant role in generating viral diversity among retroviruses (Onafuwa-Nuga & 239 
Telesnitsky, 2009). In the present study, viruses with a prior history of recombination  240 
(Bęczkowski et al., 2014a) exhibited higher evolutionary rates, which could be the 241 
result of strong immune selection pressure acting on the recombinant Envs compared 242 
to (presumably) more host adapted, evolutionary older non-recombinants. 243 
Nonetheless, the mechanisms responsible for the faster evolution of recombinants 244 
might not be related to the immune system, and could be attributed to their higher 245 
replication tempo and increased infectivity (Tebit et al., 2007). 246 
 This is the first study to demonstrate that against a background of low diversity and 247 
slow evolution for env as a whole, the leader region exhibited the highest proportion 248 
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of positively selected sites and the highest evolutionary rate among all fragments 249 
examined, but more data is required to confirm this. The N-terminal signal peptide of 250 
FIV plays an important role in post-translational targeting of the Env precursor and its 251 
translocation through the endoplasmic reticulum (ER) (Verschoor et al., 1993). 252 
Studies of viral leader sequences highlighted their enormous complexity, suggesting a 253 
role not only in post-translational events but also in post-cleavage events (Hegde & 254 
Bernstein, 2006; Lemberg & Martoglio, 2002). Leader encoded peptides are involved 255 
in self-antigen presentation (Borrego et al., 1998), a property exploited by human 256 
cytomegalovirus. This virus has a signal peptide with 9 residues identical to the MHC 257 
I signal peptides (Tomasec, 2000), which helps it to evade detection by NK cells 258 
presenting a virus-encoded MHC I molecule (Ulbrecht et al., 2000). Furthermore, 259 
sequence variation among the signalling peptides of acute and chronic isolates of HIV 260 
has also been demonstrated (Gnanakaran et al., 2011). These findings suggest that the 261 
leader may play an important role in regulating env expression on the viral surface 262 
(Hegde & Bernstein, 2006) and therefore viral infectivity. This hypothesis warrants 263 
further research and validation in functional studies. 264 
By comparing amino acid sequences and global patterns of PNGS, 19 sites were 265 
identified which were conserved in over 97% of the examined sequences, with 6 266 
PNGS displaying 100% fixed cross-clade pattern. This striking consistency at the 267 
population level suggests that glycosylation at these sites is likely to play an essential 268 
role in the folding and integrity of the viral Env. Patterns of fixed N-linked 269 
glycosylation sites have also been noted in infections with SIV (Chackerian et al., 270 
1997) and HIV-1 group M subtypes A through G (Gao et al., 1996). 271 
Statistical characterization of a relationship between within-host evolutionary 272 
dynamics and the clinical outcome of retroviral infection remains problematic. 273 
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Although HPDs permit a comparison of evolutionary rates between groups of 274 
patients, the estimate uncertainty tends to be high due to limited signal within intra-275 
host data sets (Carvajal-Rodriguez et al., 2008). We have considered hierarchical 276 
phylogenetic models (HPMs) to test for rate differences between cats, but preliminary 277 
analyses suggested limited power to detect effects in our data using these parameter-278 
rich models as also suggested by others (Edo-Matas et al., 2011). 279 
The conclusions drawn from the intra-host diversity and rates of evolution are 280 
restricted by 1) the 63% mortality rate within the Memphis cohort, 2) the relatively 281 
low number of sequences available from some cats at selected time-points, and 3) the 282 
short 12-month study period (Seo et al., 2002) and indeed we identified almost 283 
identical sequences over the 3 different sampling times. However, despite this short 284 
time frame and the potential limitations of the methodology used, we reliably 285 
quantified within-host evolution. The presence of identical amplicons in cats at 3 286 
different sampling times suggest that factors which tend to generate false diversity 287 
(polymerase template switching, PCR induced errors) did not affect our results. 288 
Furthermore, the results presented here are in agreement with previous FIV studies 289 
employing “bulk” PCR (Ikeda et al., 2004; Motokawa et al., 2005), end-point dilution 290 
proviral DNA PCR (Kraase et al., 2010) as well as a study examining sequences from 291 
plasma viral RNA (Huisman et al., 2008) and we observed low sequence variation 292 
and high genetic stability of FIV in a relatively large sample of naturally infected cats. 293 
Conclusion 294 
We observed relatively low intra-host diversity and a low rate of evolution of the 295 
entire env in cats naturally infected with FIV. The greater overall genetic stability of 296 
FIV compared to HIV-1 might explain why many naturally infected cats do not 297 
progress rapidly to AIDS. This is the first study to demonstrate that the leader 298 
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sequence is the fastest evolving region of env. Since the majority of previous studies 299 
focused on V3-V5 region, these results indicate that the role of the unusually long 300 
leader sequence of FIV env in viral infectivity and immune evasion might have been 301 
underestimated.   302 
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Methods 303 
Cats, FIV env sequences and alignments 304 
Forty four privately-owned, neutered domestic cats, of various ages, breeds and 305 
conditions of health, were enrolled into the study (Bęczkowski, 2013) based on a 306 
history of a positive FIV antibody test result (SNAP® FIV/FeLV Combo Test, 307 
IDEXX Laboratories). All cats were FeLV antigen negative and their FIV positive 308 
status was confirmed by virus isolation (Hosie et al., 2009). In the study group, 27 309 
cats lived together in a large multi-cat household in Memphis, TN, USA, where FIV-310 
positive and FIV-negative cats were housed indoors with unrestricted access to one 311 
another. The remaining 17 cats lived in individual households in Chicago, IL, USA 312 
with exception of 5 cats: 2 cats (P7 and P4) had been rehomed together and were 313 
living in the same household; 1 cat (P9) had been rehomed with another FIV-positive 314 
cat not enrolled in the study; 1 cat (P13) had been rehomed with another FIV-negative 315 
cat; and 1 cat (P21) was housed with another 2 FIV-positive cats in the rehoming 316 
centre. Cats were classified, based on a 6-monthly clinical examination by a registered 317 
specialist in feline medicine (AL), into 2 groups: 1) healthy - cats with no 318 
abnormalities found on clinical examination, and 2) unhealthy – cats with any 319 
abnormalities detected on clinical examination. At the time of enrolment, there were 320 
10 healthy (59%) and 7 not healthy (41%) cats in the Chicago cohort. In the Memphis 321 
cohort, 12 cats were classified as healthy (44%) and 15 cats were classified as 322 
unhealthy (56%) at the time of enrolment. During the study period, there was a 63% 323 
mortality rate in the Memphis cohort (17/27), while only 1 cat (5.9 %) from Chicago 324 
cohort died during the same time frame (Bęczkowski, 2013). 325 
Multiple full length FIV env genes (~2500 bp) were amplified directly from whole 326 
blood collected at 6 monthly intervals starting in January and May 2010 for Memphis 327 
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and Chicago respectively (time points A, B and C), using nested PCR protocol 328 
(Additional file 6-Table S4). First round PCR products were amplified directly from 329 
blood, without genomic DNA extraction by Phusion
®
 Blood Direct II Polymerase 330 
(Thermo Fisher Scientific) followed by direct nucleic acid sequence determination. 331 
Phusion
®
 Blood Direct II Polymerase is a proofreading polymerase with 25 fold 332 
greater accuracy than Taq DNA polymerase, determined with a modified lacI-based 333 
method (Frey & Suppmann, 1995). The nucleic acid sequence of the first-round PCR 334 
product informed the primer design for the second round PCR, which was performed 335 
using High Fidelity PCR Master (Roche), which amplifies with 3 fold greater 336 
accuracy than Taq DNA polymerase (Roche). Strain-specific primers for the second 337 
round PCR incorporated restriction sites. Amplified envs were cloned into the 338 
eukaryotic expression vector VR1012 (Hartikka et al., 1996) and transformed into E. 339 
coli MAX Efficiency® DH5α™ Competent Cells (Invitrogen). Thus constructed 340 
VR1012 plasmids expressing FIV env were sequenced (Additional file 7-Table S5) 341 
using Big Dye Terminator v1.1 kit (Applied Biosystems) for the purpose of the 342 
present study, before being assessed in functional studies (Bęczkowski et al., 2014b; 343 
Bęczkowski et al., 2014c). Special measures were taken to avoid the possibility of 344 
contamination, in both the clinical and laboratory settings: cats were double identified 345 
prior to blood sampling, PCR reactions were prepared in a designated UV treated 346 
room, and fresh, unopened reagents were used at each separate time point throughout 347 
the study.  348 
There were 355 serial env sequences from 43 cats available for analysis from the 2 349 
cohorts (Additional file 7-Table S5). The number of sequences varied according to the 350 
availability of follow-up samples, being largely influenced by the 63% mortality rate 351 
within the Memphis cohort. Multiple sequence alignments were conducted in 352 
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MEGA5 (Tamura et al., 2011) and curated manually to ensure homology of gaps in 353 
sequences of variable length. Analyses were performed using the entire env DNA 354 
sequences and the 3 structural fragments: 1) leader/signal region (approx. 509 bp in 355 
length); 2) variable V3-V5 region (approx. 630bp); and 3) remaining concatenated 356 
fragments of the entire env after exclusion of the V3-V5 region, denoted NV (approx. 357 
1900bp). The temporal signal and ‘clocklikeness’ of the env phylogenies were tested 358 
in Path-o-Gen (http://tree.bio.ed.ac.uk), (Additional file 8-Table S6). 359 
Phylogenetic trees 360 
Maximum likelihood (ML) trees were constructed in MEGA5 (Tamura et al., 2011) 361 
under the HKY nucleotide substitution model, selected through jMODELTEST 362 
analysis (Posada, 2008). Statistical support for ML tree was estimated using 363 
bootstrapping analysis with 1000 replicates (Efron et al., 1996). The ML tree 364 
constructed using the entire data set was carefully examined for evidence of non-365 
monophyletic clustering of multiple sequences amplified from each individual. 366 
Sequences from 3 animals (M5, P8 and P21), amplified at different time points did 367 
not form monophyletic groups and were excluded from further intra-host and 368 
evolutionary rate analyses. 369 
Intra-host diversity 370 
Intra-host sequence variation among the env sequences and 3 fragments of the gene: 371 
1) leader, 2) V3-V5 and 3) NV at each time point were calculated as mean and highest 372 
pairwise distances under HKY nucleotide substitution model in PAUP 4.0 b10 373 
(Wilgenbusch & Swofford, 2002). To explore the variation in mean pairwise 374 
distances of 3 structural fragments of the env a General Linear Model (GLM) (Khan, 375 
2013) was used with “structural fragment of the env” and “time point” as fixed effects 376 
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and “cat” as a random effect. No evidence of recombination within hosts was found 377 
using rigorous five-fold recombination testing (Bęczkowski et al., 2014a). 378 
Selection and PNGS 379 
Nucleotide sites under diversifying or purifying selection were identified and dN/dS 380 
ratios (ω) for every codon in the alignment, were estimated using three different 381 
methods: 1) single likelihood ancestor counting (SLAC) (Kosakovsky Pond & Frost, 382 
2005) at p<0.01,  2) fixed effects likelihood (FEL) (Kosakovsky Pond & Frost, 2005) 383 
at p<0.1, and 3) internal fixed effects likelihood (IFEL) (Kosakovsky Pond et al., 384 
2006b) at p<0.1. To focus on the most strongly supported positively selected sites, we 385 
reported those sites which were consistently identified by all three methods. 386 
Potential N-linked glycosylation sites and their position in the protein alignment were 387 
identified by N-GlycoSite tool available at Los Alamos National Laboratory web 388 
server (http://www.hiv.lanl.gov/) and the number of sequences with glycosylation 389 
sites was counted. The analysis included reference sequences from GenBank 390 
representing clades A, B, C and D: Aomori 1 [GenBank:D37816], Aomori 2 391 
[GenBank:D37817.1], FIV C [GenBank:AF474246.1], Dixon [GenBank:L00608.1], 392 
Dutch [GenBank:X60725], Fukuoka [GenBank:D37815.1], Sendai 1 393 
[GenBank:D37813.1], Shizuoka [GenBank:D37811.1], UK2 [GenBank:X69494.1], 394 
UK8 [GenBank:X69496.1], USIL2489 [GenBank:U11820.1], Yokohama 395 
[GenBank:D37812.1], Petaluma [GenBank:M25381.1], PPR [GenBank:M36968.1] 396 
and sequences from all cats excluding identical, duplicate sequences (n=329). 397 
Alignments were numbered according to positions in the M49C C76 sequence. 398 
Rate of molecular evolution  399 
Rates of evolution of the entire env gene and individual fragments from each 400 
Memphis and Chicago cohorts and all cats were estimated using Bayesian 401 
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Evolutionary Analysis Sampling Trees (BEAST) version v.1.7.1 (Drummond & 402 
Rambaut, 2007), based on sampling date information. Additionally, rate comparisons 403 
were made between non-recombinant or recombinant sequences, sequences from 404 
healthy and sick cats, and cats from Memphis that remained alive and those that died 405 
during the study period. 406 
Sequence alignments from animals from which data were available from more than 1 407 
time point were included in the analysis: 17 cats from Memphis (197 sequences) and 408 
12 cats from Chicago (108 sequences). The analysis of differences in evolutionary 409 
rate between sequences from alive (n=6) and deceased cats (n=11), was based on 410 
sequences from Memphis cohort. The HKY evolutionary model of substitution with 411 
four category gamma distribution was selected with codon positions (1+2) and 3 as 412 
partitions (Shapiro et al., 2006). The analyses in BEAST were performed estimating 413 
independent trees for each cat, with a linked clock rate parameter across individual 414 
cats, under strict and relaxed lognormal clock models with uniform distribution clock 415 
rate priors, informed by previous estimates of evolutionary rates for FIV and HIV 416 
(Table 1). The length of MCMC chain was set for 200,000,000 iterations with 417 
20,000,000 burn-in and was run until convergence and effective sample sizes >100 418 
were obtained.  419 
The BEAST generated output log file was analysed in TRACER v1.5. The coefficient 420 
of variation in rates among branches was used to determine whether a relaxed 421 
molecular clock was more appropriate for these data. This was assumed to be the case 422 
if the estimate for the coefficient of variation excluded zero.  423 
The statistical support is provided in the form of parameter estimates and their highest 424 
posterior densities (HPD).  425 
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The study and its aims were reviewed and approved by the University of Glasgow 426 
Ethics Committee and the Purdue Animal Care and Use Committee. Cat owners 427 
provided written informed consent for their participation in the study. 428 
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Tables 745 
 746 
Table 1 - Comparison of evolutionary rates of the env gene of HIV-1 and 747 
fragments of the env of FIV-Fca (FIV strain of domestic cat) and FIV-Pco (FIV 748 
strain of cougar).  749 
Virus Evolutionary rate (x10
-3
 substitutions 
per site per year) 
Study 
HIV-1 gp160 env 2.4 (1.8-2.8)* (Korber et al., 2000) 
FIV-Fca V3-V6 env 3.1-6.6 (2.2–4.1, 5.0–8.4, 3.3–9.2)*1 (Hayward & Rodrigo, 2010) 
FIV-Pco V4-V5 env 1.54 (0.89-2.23)* (Biek et al., 2003) 
FIV-Fca V1-V2 env 3.4
ζ
 (Greene et al., 1993) 
FIV-Fca V1-V9 env 0.9
Ɨ
 (0.18-1.59)*-6.7
§
 (1.72-13.35)*  (Kraase et al., 2010) 
 750 
*95% lower and upper highest posterior density (HPD),
1
95 % HPD for each of three 751 
cats (Hayward & Rodrigo, 2010), Ɨ 322 weeks post infection, §12 weeks post infection 752 
(Kraase et al., 2010), ζ evolutionary rate estimated using method of Gojobori and 753 
Yokoyama (Greene et al., 1993).   754 
 - 35 - 
Figures 755 
 756 
Fig. 1 - Maximum likelihood (ML) tree, based on the HKY model, rooted on a 757 
clade C reference FIV env. The tree is drawn to scale, with branch lengths measured 758 
in the number of substitutions per site. The ML phylogeny includes 47 entire env 759 
nucleotide sequences (representative of a total of 355 sequences from Chicago and 760 
Memphis), 15 entire env sequences derived from GenBank; accession numbers: 761 
Aomori 1 [GenBank:D37816], Aomori 2 [GenBank:D37817.1], FIV C 762 
[GenBank:AF474246.1], Dixon [GenBank:L00608.1], Dutch [GenBank:X60725], 763 
Fukuoka [GenBank:D37815.1], Sendai 1 [GenBank:D37813.1], Shizuoka 764 
[GenBank:D37811.1], UK2 [GenBank:X69494.1], UK8 [GenBank:X69496.1], 765 
USIL2489 [GenBank:U11820.1], Yokohama [GenBank:D37812.1], Petaluma 766 
[GenBank:M25381.1], PPR [GenBank:M36968.1], Leviano [GenBank:FJ374696.1], 767 
3 V3-V5 region sequences representing Clade E: LP3 [GenBank:D84496], LP20 768 
[GenBank:D84498], LP24 [GenBank:D84500] and 1 shorter 504 bp in length RUS14 769 
[GenBank:EF447297] sequence. Taxa with inconsistent clade assignment are 770 
represented with an asterisk (P8, P21). Non-monophyletic taxa from cat M5 are 771 
marked with triangle. Only bootstrap values above 80 are shown. 772 
 773 
Fig. 2 - Comparison of mean pairwise distances between env fragments and 774 
entire env sequences amplified from 3 samplings (A, B and C on the x axis). 775 
Median values for the leader, V3-V5, NV and env respectively for: 1) time point A: 776 
(0.20%, 0.11%, 0.16% and 0.13%), 2) time point B: (0.20%, 0.12%, 0.12% and 777 
0.11%), 3) time point C: (0.27%, 0.19%, 0.14% and 0.17%).  778 
 779 
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Fig. 3 - Frequency and location of predicted PNGS (a) and sites under positive 780 
selection (b) with corresponding dN/dS values. PNGS at positions 303, 335, 347, 781 
536, 553 and 738 represent fixed sequons among all clades of FIV from different 782 
geographic origins (n=329). Sequons at positions 263, 279, 423, 427, 504, 734 and 783 
341, 523, 746 were also fixed and were present in >99% of sequences. Positively 784 
selected sites (n=10) were consistently identified by three different detection methods 785 
(for detail see Additional file 4-Table S2). Leader sequence and B cell epitope regions 786 
identified in previous studies are highlighted in grey. The putative leader sequence 787 
cleavage site is located at the position 528 bp from the start codon of the env ORF of 788 
reference FIV Petaluma [GenBank: M25381.1]. Location of V1-V8 regions is 789 
highlighted below the graphs. 790 
 791 
Fig. 4 - Distribution of the evolutionary rates calculated for the: 1) leader, 2) 792 
V3V5 fragment, 3) NV fragment and 4) entire env gene. Evolutionary rates are 793 
compared between sequences amplified from Memphis (M), Chicago (C) and all cats 794 
(SG). Rate estimates were either based on strict or relaxed clock models (for details 795 
see Additional file 5-Table S3). 796 
 797 
Fig. 5 - Comparison of evolutionary rates of the leader, V3-V5, NV fragments 798 
and the entire env genes from 6 alive (healthy, A) and 11 deceased (sick, D) cats 799 
from Memphis cohort during the 12 month observation period. Rate estimates 800 
were either based on strict or relaxed clock models (for details see Additional file 5-801 
Table S3).   802 
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Additional files 803 
 804 
Additional file 1 – The Maximum Likelihood (ML) tree constructed under HKY 805 
substitution model using the entire data set. The tree is saved in the NEWICK 806 
format and can be opened in FigTree v 1.3.1 (http://tree.bio.ed.ac.uk/). 807 
 808 
Additional file 2 – Fig. S1 Maximum Likelihood tree of 35 env sequences 809 
amplified from male cat M10 (in red) and 2 closely related cats (M1 (in blue) and 810 
M11 (in green)) rooted on reference clade B env sequence. 811 
 812 
Additional file 3 – Table S1 Mean and highest pairwise distances (percentages) 813 
calculated for consecutive env sequences and its fragments, obtained from 3 814 
blood samples (A, B and C) collected at 6 monthly intervals starting in January 815 
and May 2010 for Memphis and Chicago respectively.  816 
 817 
Additional file 4 - Table S2 Positively selected sites identified by three different 818 
detection methods: 1) SLAC (p<0.01), 2) IFEL (p<0.1) and 3) FEL (p<0.1).  819 
 820 
Additional file 5 - Table S3 Evolutionary rates of the entire env, and structural 821 
fragments of the env estimated under relaxed and strict clock models for 822 
Memphis and Chicago cohorts and the entire study group.  823 
 824 
Additional file 6 – Table S4 Primers. 825 
 826 
Additional file 7 – Table S5 Number of sequences detected at each time point 827 
from the US cats.  828 
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 829 
Additional file 8 - Table S6 Results of investigation of the temporal signal and 830 
‘clocklikeness’ of env phylogenies, from Memphis and Chicago cats. 831 
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